FPMI

FluoroPharma Medical (PK) Stock Price

0.0023
-0.0017 (-42.5%)
0.0023
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
FluoroPharma Medical Inc (PK) FPMI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0017 -42.5% 0.0023 16:30:11
Close Price Low Price High Price Open Price Previous Close
0.0023 0.0023 0.0023 0.0023 0.004
Bid Price Ask Price Spread News
0.0016 0.259 0.2574 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1 12,500 $ 0.0023 $ 29 11,731 0.0011 - 0.018
Last Trade Time Type Quantity Stock Price Currency
11:02:30 12,500 $ 0.0023 USD

FluoroPharma Medical (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 79.33k 34.49M 21.76M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

FluoroPharma Medical (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FPMI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.00230.000.0000.000.0%
1 Month0.00220.0040.00220.00356917,0000.00014.55%
3 Months0.00260.00440.00210.002427636,329-0.0003-11.54%
6 Months0.00280.00510.0020.002659635,772-0.0005-17.86%
1 Year0.01110.0180.00110.003138652,833-0.0088-79.28%
3 Years0.030.250.00110.050700144,299-0.0277-92.33%
5 Years0.2750.440.00110.120340843,357-0.2727-99.16%

FluoroPharma Medical (PK) Description

We are a molecular imaging company headquartered in Montclair, NJ. The Company was founded to engage in the discovery, development and commercialization of proprietary products for the positron emission tomography (PET) market. The Company's initial focus has been on the development of novel cardiovascular imaging agents that can more efficiently and effectively detect and assess acute and chronic forms of coronary artery disease (CAD). Molecular imaging pharmaceuticals are radiopharmaceuticals that enable early detection of disease through the visualization of subtle changes in biochemical and biological processes.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.